(*) USA Approval Date: 2021. 12.17
(*) USA Approval Date: 2023. 02.02>
(*) USA Launch Date: 2022. 01.13
Company
Generic Name: TEZEPELUMAB
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 12.21
RTM
RTM Web-Site
TSLP: Thymic Stromal LymphoPoietin
UpDate: 2023. 02.08